These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 24491888)
1. Effective management of hemoptysis via endobronchial application of Ankaferd hemostat. Uzun O; Erkan L; Haznedaroglu IC Arch Bronconeumol; 2014 Sep; 50(9):407-9. PubMed ID: 24491888 [TBL] [Abstract][Full Text] [Related]
2. Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis. Leblebisatan G; Bay A; Karakus SC; Kekilli M; Haznedaroglu IC Blood Coagul Fibrinolysis; 2012 Sep; 23(6):494-7. PubMed ID: 22576286 [TBL] [Abstract][Full Text] [Related]
3. Endoscopic topical application of Ankaferd Blood Stopper® in gastrointestinal bleeding. Karaman A; Baskol M; Gursoy S; Torun E; Yurci A; Celikbilek M; Guven K; Ozbakir O; Yucesoy M J Altern Complement Med; 2012 Jan; 18(1):65-8. PubMed ID: 22268970 [TBL] [Abstract][Full Text] [Related]
4. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis. Kurt M; Akdogan M; Onal IK; Kekilli M; Arhan M; Shorbagi A; Aksu S; Kurt OK; Haznedaroglu IC Dig Liver Dis; 2010 Mar; 42(3):196-9. PubMed ID: 19540818 [TBL] [Abstract][Full Text] [Related]
5. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability. Kurt M; Oztas E; Kuran S; Onal IK; Kekilli M; Haznedaroglu IC Am J Emerg Med; 2009 Jun; 27(5):631.e1-2. PubMed ID: 19497484 [TBL] [Abstract][Full Text] [Related]
6. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Bilgili H; Kosar A; Kurt M; Onal IK; Goker H; Captug O; Shorbagi A; Turgut M; Kekilli M; Kurt OK; Kirazli S; Aksu S; Haznedaroglu IC Med Princ Pract; 2009; 18(3):165-9. PubMed ID: 19349716 [TBL] [Abstract][Full Text] [Related]
7. Prohemostatic and antithrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses. Ozel-Demiralp D; Igci N; Ayhan B; Egin Y; Haznedaroglu IC; Akar N Clin Appl Thromb Hemost; 2012 Nov; 18(6):604-10. PubMed ID: 22327821 [TBL] [Abstract][Full Text] [Related]
8. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience. Baykul T; Alanoglu EG; Kocer G J Contemp Dent Pract; 2010 Jan; 11(1):E088-94. PubMed ID: 20098971 [TBL] [Abstract][Full Text] [Related]
9. First clinical experience of Ankaferd BloodStopper as a hemostatic agent in partial nephrectomy. Huri E; Akgül T; Ayyildiz A; Bağcioğlu M; Germiyanoğlu C Kaohsiung J Med Sci; 2010 Sep; 26(9):493-5. PubMed ID: 20837346 [TBL] [Abstract][Full Text] [Related]
10. Topical application of ankaferd hemostat in a patient with gastroduodenal amyloidosis complicated with gastrointestinal bleeding. Beyazit Y; Onder FO; Torun S; Tas A; Purnak T; Tenlik I; Turhan N Blood Coagul Fibrinolysis; 2013 Oct; 24(7):762-5. PubMed ID: 23751610 [TBL] [Abstract][Full Text] [Related]
12. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Kurt M; Kacar S; Onal IK; Akdogan M; Haznedaroglu IC Endoscopy; 2008 Sep; 40 Suppl 2():E262. PubMed ID: 19090459 [No Abstract] [Full Text] [Related]
13. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content. Beyazit F; Beyazit Y; Tanoglu A; Haznedaroglu IC Med Hypotheses; 2020 Oct; 143():110150. PubMed ID: 32763660 [TBL] [Abstract][Full Text] [Related]
14. Successful management of bleeding after dental procedures with application of blood stopper: a single center prospective trial. Beyazit Y; Kart T; Kuscu A; Arslan A; Kurt M; Aktas B; Kekilli M; Haznedaroglu I J Contemp Dent Pract; 2011 Sep; 12(5):379-84. PubMed ID: 22269200 [TBL] [Abstract][Full Text] [Related]
15. The effect of ankaferd blood stopper used for massive haemoptysis in a patient with mounier-kuhn syndrome: A case report. Yazici O; Gulen ST; Ceylan E J Pak Med Assoc; 2020 Apr; 70(4):731-733. PubMed ID: 32296224 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the hemostatic effects of Ankaferd blood stopper during dental extractions in patients on antithrombotic therapy. Çakarer S; Eyüpoğlu E; Günes ÇÖ; Küseoğlu BG; Berberoğlu HK; Keskin C Clin Appl Thromb Hemost; 2013; 19(1):96-9. PubMed ID: 22327817 [TBL] [Abstract][Full Text] [Related]
17. Successful topical application of Ankaferd blood stopper in a patient with life-threatening fundal variceal bleeding despite cyanoacrilate injection. Beyazit Y; Akdogan M; Sayilir A; Torun S; Suvak B; Kurt M Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):e9-11. PubMed ID: 21868302 [TBL] [Abstract][Full Text] [Related]
18. A new hemostatic agent--Ankaferd blood stopper: management of gastrointestinal bleeding in an infant and other experiences in children. Yarali N; Oruc M; Bay A; Dalgic B; Bozkaya IO; Arıkoglu T; Kara A; Tunc B Pediatr Hematol Oncol; 2010 Nov; 27(8):592-6. PubMed ID: 20863156 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model. Iynen I; Sogut O; Kose R Otolaryngol Head Neck Surg; 2011 Nov; 145(5):840-4. PubMed ID: 21750339 [TBL] [Abstract][Full Text] [Related]